All Posts

Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Market Trends Analysis
Exploring the Metastatic Castration-Sensitive Prostate Cancer Market Landscape

Prostate cancer is the third most frequent cancer in the United States and the fourth most common worldwide. 1 in every 9 males in the United States will be diagnosed with Prostate Cancer at some time in their life. According to the American Cancer Society, Prostate Cancer is the second largest cause of cancer mort...

Find More

MedTech News and Updates for NeuroLogica, Cordis, OSF Ventures, Rockley Photonics, Medtronic, NovaSight and Cardiawave
NeuroLogica’s OmniTom Elite; Cordis’s S.M.A.R.T. RADIANZ Vascular Stent System; Rockley Photonics and Medtronic’s Collaboration; NovaSight’s Amblyopia Treatment Device; Cardiawave’s VALVOSOFT; OSF Ventures invests in wireless seizure detection sensor

NeuroLogica Announces FDA 510(k) Clearance for Photon Counting Computed Tomography Using OmniTom Elite  On March 10, 2022, The state-of-the-art OmniTom Elite acquired 510(k) approval for the addition of Photon Counting Detector (PCD) technology, according to NeuroLogica Corp, a subsidiary of Samsung Electro...

Find More

Potential of Cannabidiol (CBD) as a Treatment Substance
Can Cannabinoids be an Effective Medicinal Substance?

Cannabidiol (CBD) is one of the 120 cannabinoids present naturally in cannabis plants. After tetrahydrocannabinol (THC), Cannabidiol is the second most prevalently available cannabinoid. Cannabidiol, an important component of medicinal marijuana, is either directly from the hemp plant or synthesized in a laboratory...

Find More

pharma news and updates for AstraZeneca, AbbVie, Sandoz, Incyte, Venatorx, and Bayer
AstraZeneca and Merck’s Lynparza; Venatorx’s cefepime-taniborbactam; AbbVie’s Qulipta; AstraZeneca’s IL-5 inhibitor Fasenra; Sandoz Acquires Coalesce; Incyte’s Opxelura; Bayer’s Nubeqa; NICE Rejects Keytruda Plus Chemotherapy

FDA Clears AstraZeneca and Merck’s Lynparza as an Adjuvant Breast Cancer Therapy The FDA approved the AstraZeneca and Merck drug for a specific group of patients with high-risk early breast cancer after chemotherapy treatment, either before or after surgery. Lynparza cements its position as the best-selling PARP...

Find More

Emerging Drugs In Small Cell Lung Cancer Treatment Market
Small Cell Lung Cancer Treatment Market Propels Due to Extremely Robust Pipeline

Small Cell Lung Cancer (SCLC) is a particularly aggressive type of lung cancer. It is distinguished by the rapid and uncontrolled growth of certain cells in the lungs. A tumor forms eventually, and cancer can spread to other parts of the body. Small Cell Lung Cancer treatment usually involves chemotherapy, radiothe...

Find More

Most Prominent Players in Nerve Repair and Regeneration Market

Peripheral nerve injuries were historically became known to mankind on the battlefield during Second World War. With technological advancements over the years, peripheral nerve injuries (PNI) have become more common which can be attributed to various reasons such as traumatic injuries, gunshot wounds, rising preval...

Find More

MedTech News and Updates for Bioventus, Valencia Technologies, SurGenTec Graftgun, Exactech, PathMaker Neurosystems, Boston Scientific
Bioventus’s StimRouter Pain Management Device; FDA Approval for eCoin Therapy; SurGenTec Launches ION Screw; Exactech’s Humeral Reconstruction Prosthesis; Boston Scientific’s WATCHMAN FLX LAAC Device; PathMaker Neuro’s MyoRegulator

Bioventus Receives 501(k) Clearance for StimRouter Pain Management Device On March 1, 2022, the US Food and Drug Administration (FDA) gave Bioventus' StimRouter Neuromodulation System 510(k) approval. The next-generation pain treatment device is intended to treat chronic pain caused by peripheral nerves, ex...

Find More

Key Companies Dominating the Global Bone Densitometers Market
Evaluating the Top Players in the Global Bone Densitometers Market

Bone densitometers are the diagnostic systems with an enhanced X-ray technology known as dual-energy X-ray absorptiometry or DXA/DEXA technology that is capable of measuring the bone mineral density level. Bone mineral density (BMD) is an assessment of inorganic mineral content present in bone and is one of the ...

Find More

Latest Pharma News and Updates for Lilly Amgen Roche Pfizer Civica Nacto
Lilly & Boehringer’s Jardiance; BMS Secures a Neoadjuvant Market for Opdivo; Amgen & NHS Signs a Deal; Roche’s Alzheimer Drug gantenerumab; Pfizer’s RSV Vaccine; Civica’s Insulin Biosimilars; Eli Lilly & Incyte’s JAK inhibitor Olumiant; Natco Pharma Launches Revlimid Generic

Eli Lilly, Boehringer Ingelheim’s Jardiance Giving Competition to AstraZeneca’s Farxiga with EU Approval Jardiance, the diabetes blockbuster from Eli Lilly and Boehringer Ingelheim, recently received a Heart Failure label expansion in the United States. Now, the drug is expanding into Europe, with a nod that mig...

Find More

Top Liquid Biopsy Companies
Top Five Liquid Biopsy Companies Impacting Cancer Diagnostics Market from 2020 to 2028

Cancer diagnostics is an umbrella term that encompasses all diagnostics modalities such as imaging, molecular diagnostics, and biopsy employed in drawing conclusions regarding cancer diagnosis and devising prognostic strategies.  Liquid Biopsy is comparatively a new technique in the cancer diagnosis and the...

Find More